Table 6.
Association of nighttime fasting and prostate cancer risk stratified by chronotype (missing for 19 controls and for 1 case).
| Nighttime Fasting | Controls N (%) | Cases N (%) | OR (95% CI) a | OR (95% CI) b |
|---|---|---|---|---|
| Morning chronotype | ||||
| ≤11 h | 219 (52.3) | 170 (55.5) | Ref | Ref |
| >11 h | 200 (47.7) | 136 (44.5) | 0.84 (0.61–1.15) | 0.70 (0.47–1.04) |
| Intermediate chronotype | ||||
| ≤11 h | 181 (59.7) | 130 (58.0) | Ref | Ref |
| >11 h | 122 (40.3) | 94 (42.0) | 0.97 (0.67–1.41) | 0.80 (0.50–1.27) |
| Evening chronotype | ||||
| ≤11 h | 65 (60.7) | 41 (53.9) | Ref | Ref |
| >11 h | 42 (39.3) | 35 (46.1) | 1.17 (0.63–2.18) | 0.99 (0.51–1.92) |
N = sample size; OR = odds ratio; 95% CI = 95% confidence interval. a Adjusted for age, center and education. b Adjusted for age, center, education, diabetes (missing for 2 controls and 2 cases), indoor ALAN exposure (missing for 4 controls and 2 cases) and time of first intake.